Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy

CONCLUSION: In this review, we discuss the mechanisms of EGFR-TKIs drug resistance and the clinical strategies to overcome drug resistance from the perspective of EGFR-TKIs combined treatment.PMID:34661758 | DOI:10.1007/s00432-021-03828-8

Source: Clinical Lung Cancer - October 18, 2021 Category: Cancer & Oncology Authors: Yuxin Zhao Haiyong Wang Chengwei He Source Type: research